-
1
LipidA-IDER to explore the global lipid A repertoire of drug-resistant gram-negative bacteria
Published 2023Get full text
Journal Article -
2
Outer-membrane permeabilization, LPS transport inhibition: activity, interactions, and structures of thanatin derived antimicrobial peptides
Published 2024“…Currently, viable antibiotics available to mitigate infections caused by drug-resistant Gram-negative bacteria are highly limited. Thanatin, a 21-residue-long insect-derived antimicrobial peptide (AMP), is a promising lead molecule for the potential development of novel antibiotics. …”
Get full text
Journal Article -
3
Linking dual mode of action of host defense antimicrobial peptide thanatin: structures, lipopolysaccharide and LptAm binding of designed analogs
Published 2022“…At present, antibiotics options to cure infections caused by drug resistant Gram-negative pathogens are highly inadequate. …”
Get full text
Journal Article -
4
Designer broad-spectrum polyimidazolium antibiotics
Published 2021“…We synthesized several cationic peptide mimics, main-chain cationic polyimidazoliums (PIMs), and discovered that, although select PIMs show little acute mammalian cell toxicity, they are potent broad-spectrum antibiotics with activity against even pan-antibiotic-resistant gram-positive and gram-negative bacteria, and mycobacteria. …”
Get full text
Journal Article